125 related articles for article (PubMed ID: 24646085)
1. Genetic, genomic and epigenetic studies as tools for elucidating disease pathogenesis in primary Sjögren's syndrome.
Miceli-Richard C; Criswell LA
Expert Rev Clin Immunol; 2014 Apr; 10(4):437-44. PubMed ID: 24646085
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations in primary Sjögren's syndrome - an overview.
Imgenberg-Kreuz J; Sandling JK; Nordmark G
Clin Immunol; 2018 Nov; 196():12-20. PubMed ID: 29649576
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome.
Yin H; Zhao M; Wu X; Gao F; Luo Y; Ma L; Liu S; Zhang G; Chen J; Li F; Zuo X; Lu Q
J Dermatol Sci; 2010 Sep; 59(3):198-203. PubMed ID: 20724115
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.
Imgenberg-Kreuz J; Sandling JK; Almlöf JC; Nordlund J; Signér L; Norheim KB; Omdal R; Rönnblom L; Eloranta ML; Syvänen AC; Nordmark G
Ann Rheum Dis; 2016 Nov; 75(11):2029-2036. PubMed ID: 26857698
[TBL] [Abstract][Full Text] [Related]
5. Genetics and epigenetics in primary Sjögren's syndrome.
Imgenberg-Kreuz J; Rasmussen A; Sivils K; Nordmark G
Rheumatology (Oxford); 2021 May; 60(5):2085-2098. PubMed ID: 30770922
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome.
Charras A; Konsta OD; Le Dantec C; Bagacean C; Kapsogeorgou EK; Tzioufas AG; Pers JO; Bordron A; Renaudineau Y
Ann Rheum Dis; 2017 Mar; 76(3):625-628. PubMed ID: 28093418
[TBL] [Abstract][Full Text] [Related]
7. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.
Konsta OD; Charras A; Le Dantec C; Kapsogeorgeou E; Bordron A; Brooks WH; Tzioufas AG; Pers JO; Renaudineau Y
Bull Group Int Rech Sci Stomatol Odontol; 2016 Jun; 53(1):e01. PubMed ID: 27352422
[TBL] [Abstract][Full Text] [Related]
10. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
11. Current views on the pathogenesis of Sjögren's syndrome.
Pontarini E; Lucchesi D; Bombardieri M
Curr Opin Rheumatol; 2018 Mar; 30(2):215-221. PubMed ID: 29227354
[TBL] [Abstract][Full Text] [Related]
12. Emerging trends in Sjögren's syndrome: basic and translational research.
Gallo A; Baldini C; Teos L; Mosca M; Bombardieri S; Alevizos I
Clin Exp Rheumatol; 2012; 30(5):779-84. PubMed ID: 23009759
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
[TBL] [Abstract][Full Text] [Related]
14. Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome.
Appel S; Le Hellard S; Bruland O; Brun JG; Omdal R; Kristjansdottir G; Theander E; Nordmark G; Kvarnström M; Eriksson P; Rönnblom L; Wahren-Herlenius M; Jonsson R
Ann Rheum Dis; 2011 Jul; 70(7):1327-9. PubMed ID: 21450750
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in Primary Sjögren's Syndrome.
Bordron A; Devauchelle-Pensec V; Le Dantec C; Capdeville A; Brooks WH; Renaudineau Y
Adv Exp Med Biol; 2020; 1253():285-308. PubMed ID: 32445100
[TBL] [Abstract][Full Text] [Related]
16. [Sjögren's syndrome in the elderly].
Gentric-Tilly A
Ann Med Interne (Paris); 2002 Oct; 153(6):378-82. PubMed ID: 12486386
[TBL] [Abstract][Full Text] [Related]
17. One year in review 2020: pathogenesis of primary Sjögren's syndrome.
Bombardieri M; Argyropoulou OD; Ferro F; Coleby R; Pontarini E; Governato G; Lucchesi D; Fulvio G; Tzioufas AG; Baldini C
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):3-9. PubMed ID: 33025887
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN signature in primary Sjögren's syndrome patients.
Brkic Z; Versnel MA
Expert Rev Clin Immunol; 2014 Apr; 10(4):457-67. PubMed ID: 24450331
[TBL] [Abstract][Full Text] [Related]
19. Analysis of parotid glands of primary Sjögren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets.
Stea EA; Routsias JG; Samiotaki M; Panayotou G; Papalambros E; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2007 Jan; 147(1):81-9. PubMed ID: 17177966
[TBL] [Abstract][Full Text] [Related]
20. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
Kolkowski EC; Reth P; Pelusa F; Bosch J; Pujol-Borrell R; Coll J; Jaraquemada D
J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
